services
Expert Weight Loss Programme
Combining Styku 3D Scans, GLP-1 Medication (Wegovy, Mounjaro, Ozempic), & Nutritionist Support
If you’re living in Banbury and struggling with weight loss, you’re not alone — and you’re not without options. At ClinicAll Banbury, we offer a medically-led, fully supported weight loss programme that goes beyond the scales.
Combining the latest in Styku 3D body scanning technology, licensed GLP-1 medications (Wegovy, Mounjaro, Ozempic), and tailored support from expert Nutritionist Louise Kenny with Medications from ClinicAll director and prescriber Daniel Boyd, our service is designed to help patients with a high BMI achieve safe, sustainable results — all in line with NICE guidance.
Precision Progress Tracking with Styku in Banbury
Many weight loss plans overlook the fact that body composition matters just as much as total weight. That’s why we use the Styku 3D body scanner, now available in our Banbury clinic.
Styku creates a detailed 3D model of your body, tracking fat loss, muscle gain, and circumference changes over time — ideal for monitoring central (abdominal) fat that’s linked to greater health risks.
Why our Banbury patients love it
- Quick, private and non-invasive
- See progress visually, not just numerically
- Motivation you can measure
Dan is a Legend – has never let me down and I have followed him wherever he is working.
GLP-1 (Wegovy, Mounjaro, Ozempic) Weight Loss Medications Now Prescribed in Banbury
At ClinicAll Banbury, we offer prescription access to Wegovy, Mounjaro and Ozempic, following a thorough clinical assessment and transparent relationship with your GP. These GLP-1 medications are backed by robust clinical trials and NICE guidance for patients with a BMI ≥35, or ≥30 with certain health risks.
How they work
- Mimic natural gut hormones to reduce appetite
- Help control blood sugar and delay stomach emptying
- Support significant and sustained weight loss when combined with lifestyle changes
Clinical studies show
At NMU Banbury, prescriptions are managed in-house, ensuring safe, supported use under the guidance of our expert team.
15%
Wegovy
Up to 15% average weight loss
(Wilding et al., 2021) NICE TA875
22.5%
Mounjaro
Up to 22.5% average weight loss
(Jastreboff et al., 2022) NICE TA1026
Louise Kenny
nutritionist
Louise is our lead nutritionist in Banbury, works closely with each patient to deliver personalised care and practical support. Louise’s approach is rooted in evidence-based nutrition, emotional wellbeing, and real-life strategies that stick.
She offers:
- Tailored meal and lifestyle planning
- Education on eating well with GLP-1 meds
- Support for emotional eating and long-term habits
- Coordination with Styku data to guide nutritional adjustments
With Louise by your side, you’ll never feel like you’re doing this alone.
What’s Included in Our Banbury Weight Loss Programme?
- Full clinical assessment & medication eligibility review (report shared with NHS GP)
- Ongoing prescriptions for Wegovy, Mounjaro, or Ozempic
- Regular Styku body scans to track fat loss
- Personalised support with Louise Kenny, Banbury-based Nutritionist
- Regular check-ins and adjustments to support long-term success
Your Banbury
Weight Loss Solution
Starts Here
Whether you’ve tried diets that didn’t work, or you’re looking for medical support to finally take control of your health, our NMU Banbury team is here to help.
Book your consultation today and take the first step toward a healthier, more confident you — with cutting-edge tools and compassionate care tailored to Banbury locals.
Still got questions?
Take a look at our FAQ page or contact us
References:
- Wilding J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
- Jastreboff A.M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.
- NICE Guidance NG245 (2023). Obesity: identification, assessment and management.
- Styku. 3D Body Scanning for Weight Loss Clinics. https://www.styku.com
